Cartesian Therapeutics
RNAC
#6811
Rank
โ‚น41.05 B
Marketcap
โ‚น1,615
Share price
-1.30%
Change (1 day)
-9.33%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -โ‚น21.99 Billion

According to Cartesian Therapeutics's latest financial reports the company's current earnings are โ‚น47.93 Million. In 2023 the company made an earning of -โ‚น20.04 Billion a decrease over its 2022 earnings that were of โ‚น3.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น21.99 Billion9.73%
2023 -โ‚น20.04 Billion-724%
2022 โ‚น3.21 B-649.67%
2021 -โ‚น0.59 Billion-89.78%
2020 -โ‚น5.72 Billion25.06%
2019 -โ‚น4.58 Billion-15.68%
2018 -โ‚น5.43 Billion-0.43%
2017 -โ‚น5.45 Billion83.41%
2016 -โ‚น2.97 Billion44.3%
2015 -โ‚น2.06 Billion